| Literature DB >> 23642721 |
Mazen M Dimachkie1, Richard J Barohn.
Abstract
Guillain-Barré syndrome (GBS) is characterized by rapidly evolving ascending weakness, mild sensory loss, and hyporeflexia or areflexia. Acute inflammatory demyelinating polyneuropathy was the first to be recognized over a century ago and is the most common form of GBS. Axonal motor and sensorimotor variants have been described in the last three decades and are mediated by molecular mimicry targeting peripheral nerve motor axons. Other rare phenotypic variants have been recently described with pure sensory variant, restricted autonomic manifestations, and the pharyngeal-cervical-brachial pattern. It is important to recognize GBS and its variants because of the availability of equally effective therapies in the form of plasmapheresis and intravenous immunoglobulins.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23642721 PMCID: PMC3939842 DOI: 10.1016/j.ncl.2013.01.005
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806